Table 1 Demographic and Eligibility Characteristics by Study Group

From: Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility

Characteristics

Control n =27

DMPA n =15

P -value

Age, mean (min, max)

34.6 (23–44)

27.8 (21–38)

0.002a

Race, n (%)

  

0.13b

 White

15 (55.6)

6 (40.0)

 

 Black

9 (33.3)

9 (60.0)

 

 Asian

3 (12.5)

0 (0.0)

 

Cycle day, median (IQR)

23 (20, 26)

—

 

Days since last DMPA injection, median (IQR)

—

28.5 (13, 77)

 

Months of DMPA exposure, median (IQR)

—

15 (13, 33)

 
  1. Abbreviations: IQR, interquartile range; DMPA, depot-medroxyprogesterone acetate.
  2. aStudent’s t-test.
  3. bFisher’s exact test.
Back to article page